Evidence map›Paper›PMID 36600467›Full record

SynthesisBMJ sexual & reproductive health2023

Utilisation, effectiveness, and safety of immediate postpartum intrauterine device insertion: a systematic literature review.

Kristina Rosa Bolling, Yesmean Wahdan, Neal Warnock, Jason Lott, Juliane Schoendorf, Federica Pisa, Evelyn Gomez-Espinosa, Kristin Kistler, Brett Maiese

Abstract readSystematic Review
In one paragraph

Synthesis in BMJ sexual & reproductive health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Expanding access to postpartum contraception.Current opinion in obstetrics & gynecology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kristina Rosa BollingBayer Healthcare, Whippany, New Jersey, USA.
Yesmean WahdanBayer Healthcare, Whippany, New Jersey, USA.
Neal WarnockBayer Healthcare, Whippany, New Jersey, USA.
Jason LottBayer Healthcare, Whippany, New Jersey, USA.
Juliane SchoendorfBayer Oy, Espoo, Uusimaa, Finland.
Federica PisaBayer Schering Pharma AG, Berlin, Germany.
Evelyn Gomez-EspinosaXcenda LLC, Carrollton, Texas, USA.
Kristin KistlerXcenda LLC, Carrollton, Texas, USA kristin.kistler@xcenda.com.ORCID 0000-0001-7910-3536
Brett MaieseXcenda LLC, Carrollton, Texas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntrauterine devices (IUDs) are highly effective contraception. IUDs inserted directly following delivery provide immediate birth control and may decrease unintended pregnancies, including short-interval pregnancies, thereby mitigating health risks and associated economic burden.

methodsThis systematic literature review included published global data on the utilisation, effectiveness, and safety of postpartum intrauterine devices (PPIUDs) of any type. English language articles indexed in MEDLINE, Embase, and Cochrane from January 2010-October 2021 were included.

results133 articles met the inclusion criteria (46% interventional studies; 54% observational; n=87 from lower-income countries; n=46 from higher-income countries). PPIUD use was low in higher-income countries (6/10 000 US deliveries in 2013-2016) and varied widely in lower-income countries (2%-46%). Across both higher- and lower-income countries, in most studies (79%), >80% of women with PPIUDs had an IUD in place by 3 months; at 6 and 12 months, 76% and 54% of included studies reported that >80% of women had an IUD in place; reason for discontinuation was infrequently reported. Pregnancies were rare (96 pregnancies across 12 191 women from 37 studies reporting data) and were generally unrelated to device failure, but rather occurred in women no longer using a PPIUD. Expulsions occurred mainly in the early outpatient period and ranged widely (within 3 months: 0-41%). Abnormal bleeding, infections, or perforations were rare.

conclusionsPPIUDs are safe and effective. Long-term follow-up data are limited. Future research elucidating reasons underlying lack of PPIUD use is warranted.

Indexed as

ContraceptionIntrauterine DevicesFemaleHumansPostpartum PeriodPregnancyPregnancy, Unplannedcontraceptive effectivenessintrauterine deviceslong-acting reversible contraceptionpatient safety

Identifiers

PMID36600467
PMCPMC10176355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.